Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy

INTRODUCTION: The Livial Intervention Following Breast Cancer: Efficacy, Recurrence and Tolerability Endpoints (LIBERATE: Clinical http://Trials.gov number NCT00408863), a randomized, placebo-controlled, double-blind trial that demonstrated that tibolone (Livial), a tissue-selective hormone-replacem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bundred, Nigel J, Kenemans, Peter, Yip, Cheng Har, Beckmann, Matthias W, Foidart, Jean-Michel, Sismondi, Piero, Schoultz, Bo von, Vassilopoulou-Sellin, Rena, Galta, Rachid El, Lieshout, Eugenie Van, Mol-Arts, Mirjam, Planellas, Juan, Kubista, Ernst
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3496130/
https://ncbi.nlm.nih.gov/pubmed/22251615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3097
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars